GGrantIndex
Sort

141,003 grants matching cytokine

Gene Regulation In The Immune System

$1,006,092
Keiko Ozato · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD

Host Directed Orynotide for MDR Gram Negative Bacterial Infections

$1,005,952
Justin Blaine Schaal · University Of Southern California · R01 · FY2023 · AI

Pig-to-Monkey Islet Xenotransplantation

$1,005,885
Bernhard Josef Hering · University Of Minnesota · U01 · FY2015 · AI

Evaluation of Brain and Cognitive Changes in Older Adults with MCI Taking Lithium to Prevent Alzheimer Type Dementia

$1,005,414
Ariel Gerard Gildengers · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · AG

Immunization of Oral Mucosa for Induction of Rectal and Genital Mucosal Immunity

$1,005,250
Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2009 · DE

Myeloid - T cell interactions that sustain SIV reservoirs during effective antire

$1,005,145
Steven Grant Deeks · University Of California, San Francisco · U19 · FY2015 · AI

CTO1681 to prevent and mitigate cytokine release syndrome in CAR T-cell recipients

$1,005,131
Arthur P Bertolino · Cytoagents, Inc. · R44 · FY2025 · CA

Development of a Vaccine for HIV-AIDS: Cellular Immunity

$1,005,124
Marjorie Robert-Guroff · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA

Vaccine Development for Oral Carcinoma

$1,005,116
Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2006 · DE

Nuclear Factor-kappaB in Ovarian Cancer

$1,005,082
Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

PROBING PHOSPHORYLATION EVENTS IN BIOLOGICAL MEMBRANES

$1,004,927
Kalina Hristova · Johns Hopkins University · · FY2021 · BIO

HIV Exposed Uninfected Infant Cohort Study

$1,004,811
Donald M Thea · Boston University Medical Campus · R01 · FY2018 · HD

Early Drivers of Humoral Immunity to SARS-CoV-2 Infections

$1,004,770
Christopher L King · Case Western Reserve University · U01 · FY2023 · CA

DESIGN OF NOVEL IMMUNOGENS AND ADJUVANTS FOR HIV VACCINE

$1,004,634
Duke University · P01 · FY2003 · AI

Characterization of Signaling Pathways involved in Cell Death and Survival

$1,004,629
Srinivasa M. Srinivasula · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Targeting the checkpoint regulator VISTA for treatment of inflammatory disease

$1,004,563
Jay L Rothstein · Immunext, Inc. · R44 · FY2019 · AI

Bone marrow-targeted extracellular vesicles as a novel non-viral gene editor delivery platform

$1,004,289
Jonathan N Thon · Strm.Bio, Inc. · R44 · FY2022 · TR

Predevelopment of VV2003, a Novel CRAC Channel Inhibitor, to Improve Outcomes Associated with Checkpoint Inhibitor Immunotherapy

$1,004,278
Milton L Greenberg · Vivreon Biosciences, Llc · R44 · FY2019 · CA

Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection

$1,004,250
Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2008 · HL

Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection

$1,004,250
Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2009 · HL

Notch Mediated Expansion of Hematopoietic Precursers

$1,004,240
Irwin Bernstein · Fred Hutchinson Cancer Research Center · R24 · FY2007 · HL

Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease

$1,004,229
Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI

Chronic Kidney Disease in Children (CKiD)

$1,004,040
Bradley Alan Warady · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2009 · DK

Role of Innate and Adaptive Immune Systems in Drug-Induced Liver Disease

$1,003,841
Lance R Pohl · National Heart, Lung, And Blood Institute · ZIA · FY2014 · HL

Pathogenesis of Atopic Dermatitis

$1,003,818
Mark H. Kaplan · Indiana University Indianapolis · U19 · FY2010 · AI